| CXCR4 mutations affect presentation and outcomes in patients with Waldenström macroglobulinemia: A systematic review JJ Castillo, DF Moreno, MI Arbelaez, ZR Hunter, SP Treon Expert Review of Hematology 12 (10), 873-881, 2019 | 37 | 2019 |
| Graft-versus-host disease DF Moreno, J Cid Medicina Clínica (English Edition) 152 (1), 22-28, 2019 | 36 | 2019 |
| First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma A Oliver-Caldes, R Jiménez, M Español-Rego, MT Cibeira, ... Journal for Immunotherapy of Cancer 9 (12), 2021 | 20 | 2021 |
| Efficacy and safety of one‐day offline extracorporeal photopheresis schedule processing one total blood volume for treating patients with graft‐versus‐host disease J Cid, G Carbassé, M Suárez‐Lledó, DF Moreno, C Martínez, ... Transfusion 59 (8), 2636-2642, 2019 | 16 | 2019 |
| Treatment of patients with monoclonal gammopathy of clinical significance DF Moreno, L Rosiñol, MT Cibeira, J Bladé, C Fernández de Larrea Cancers 13 (20), 5131, 2021 | 11 | 2021 |
| Enfermedad del injerto contra el receptor DF Moreno, J Cid Medicina clínica 152 (1), 22-28, 2019 | 11 | 2019 |
| Why immunotherapy fails in multiple myeloma LG Rodríguez-Lobato, A Oliver-Caldés, DF Moreno, ... Hemato 2 (1), 1-42, 2020 | 10 | 2020 |
| Impact of intensifying primary antibiotic prophylaxis in at-home autologous stem cell transplantation program for lymphoma patients LG Rodríguez-Lobato, A Martínez-Roca, DF Moreno, G Gutiérrez-García, ... Leukemia & Lymphoma 61 (7), 1565-1574, 2020 | 9 | 2020 |
| Real‐world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45‐year period LG Rodríguez‐Lobato, A Pereira, C Fernandez de Larrea, MT Cibeira, ... British Journal of Haematology 196 (3), 649-659, 2022 | 7 | 2022 |
| Long-term responders after autologous stem cell transplantation in multiple myeloma A Oliver-Caldes, JC Soler-Perromat, E Lozano, D Moreno, A Bataller, ... Frontiers in Oncology 12, 936993, 2022 | 6 | 2022 |
| T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cells AM Battram, A Oliver-Caldés, M Suárez-Lledó, M Lozano, MB i Crespo, ... Molecular Therapy-Methods & Clinical Development 26, 207-223, 2022 | 5 | 2022 |
| Prognostic impact of MYD88 L265P mutation by droplet digital PCR in IgM MGUS and smoldering Waldenström macroglobulinemia DF Moreno, S Paz, MP Mena, M Lopez-Guerra, A Oliver-Caldes, ... Blood 138, 462, 2021 | 5 | 2021 |
| Defining an ultra-low risk group in asymptomatic IgM monoclonal gammopathy DF Moreno, A Pereira, N Tovar, MT Cibeira, L Magnano, M Rozman, ... Cancers 13 (9), 2055, 2021 | 5 | 2021 |
| Real-world evidence of daratumumab monotherapy in relapsed/refractory multiple myeloma patients and efficacy on soft-tissue plasmacytomas DF Moreno, V Clapés, JA Soler, Y González-Montes, M Gironella, ... Clinical Lymphoma Myeloma and Leukemia 22 (8), 635-642, 2022 | 4 | 2022 |
| Gene expression analysis of the bone marrow microenvironment reveals distinct immunotypes in smoldering multiple myeloma associated to progression to symptomatic disease I Isola, F Brasó-Maristany, DF Moreno, MP Mena, A Oliver-Calders, L Paré, ... Frontiers in immunology 12, 792609, 2021 | 4 | 2021 |
| Extramedullary plasmacytoma over the scar from long-lasting past surgery as presenting feature of multiple myeloma DF Moreno, X Setoain, J Bladé, L Rosiñol Archives of Clinical and Biomedical Research 4 (6), 766-774, 2020 | 3 | 2020 |
| Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease I Isola, DF Moreno, E Moga, MP Mena, N Tovar, LG Rodríguez-Lobato, ... Annals of Hematology 100 (12), 2997-3005, 2021 | 2 | 2021 |
| Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT AP Gonzalez-Rodriguez, L Lopez-Corral, DFM Fajardo, ... Bone marrow transplantation 55 (2), 461-463, 2020 | 2 | 2020 |
| Apheresis Products From Patients With Multiple Myeloma Treated With G-CSF Are a Suitable Source of T Cells for the Production of BCMA-Targeting CAR-T Cells AM Battram, A Oliver-Caldés, MB i Crespo, M Suárez-Lledó, M Lozano, ... Blood 138, 480, 2021 | 1 | 2021 |
